{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:51:49Z","timestamp":1791481909831,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173824"],"award-info":[{"award-number":["82173824"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82430114"],"award-info":[{"award-number":["82430114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104187"],"award-info":[{"award-number":["82104187"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574421"],"award-info":[{"award-number":["82574421"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2023sfy012"],"award-info":[{"award-number":["2023sfy012"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2108085QH382"],"award-info":[{"award-number":["2108085QH382"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2508085MH220"],"award-info":[{"award-number":["2508085MH220"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M700184"],"award-info":[{"award-number":["2021M700184"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021T140002"],"award-info":[{"award-number":["2021T140002"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022650","name":"Anhui Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022650","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bcp.2026.118515","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:41:30Z","timestamp":1790782890000},"page":"118515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P3","title":["GRK2\u2013JAK1 binding represses hyperproliferation of fibroblast-like synoviocytes in rheumatoid arthritis by inhibiting STAT3 activation"],"prefix":"10.1016","volume":"254","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0796-7937","authenticated-orcid":false,"given":"Chenchen","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6915-0189","authenticated-orcid":false,"given":"Fuyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0277-8827","authenticated-orcid":false,"given":"Haozhou","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzheng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huazhan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoxin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118515_b0005","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molimm.2025.06.008","article-title":"Cellular interactions in maintaining an inflammatory microenvironment in rheumatoid arthritis","volume":"184","author":"Ganeshalingam","year":"2025","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bcp.2026.118515_b0010","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","author":"anonymous","year":"2023","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.bcp.2026.118515_b0015","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/jama.2022.0786","article-title":"What is Rheumatoid Arthritis?","volume":"327","author":"Smith","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.bcp.2026.118515_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102304","article-title":"Targeting fibroblast-like synoviocytes in rheumatoid arthritis","volume":"67","author":"Tsaltskan","year":"2022","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118515_b0025","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","article-title":"Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes","volume":"16","author":"Nygaard","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bcp.2026.118515_b0030","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1093\/eurheartj\/ehab447","article-title":"The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms","volume":"42","author":"Baldini","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bcp.2026.118515_b0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41584-023-01062-9","article-title":"Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician","volume":"20","author":"Szekanecz","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bcp.2026.118515_b0040","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3390\/cells8060561","article-title":"Peficitinib Inhibits the Chemotactic activity of Monocytes via Proinflammatory Cytokine Production in Rheumatoid Arthritis Fibroblast-like Synoviocytes","volume":"8","author":"Ikari","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.118515_b0045","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.371","article-title":"Safety signal detection and evaluation in clinical development programs: a case study of tofacitinib","volume":"6","author":"Dasic","year":"2018","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.bcp.2026.118515_b0050","doi-asserted-by":"crossref","first-page":"8703","DOI":"10.12998\/wjcc.v10.i24.8703","article-title":"Recurrent herpes zoster in a rheumatoid arthritis patient treated with tofacitinib: a case report and review of the literature","volume":"10","author":"Lin","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.bcp.2026.118515_b0055","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41584-024-01153-1","article-title":"JAK inhibitor selectivity: new opportunities, better drugs?","volume":"20","author":"Virtanen","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bcp.2026.118515_b0060","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/acr2.11093","article-title":"Joint Location-specific JAK-STAT Signaling in Rheumatoid Arthritis Fibroblast-like Synoviocytes","volume":"1","author":"Hammaker","year":"2019","journal-title":"ACR Open Rheumatol."},{"key":"10.1016\/j.bcp.2026.118515_b0065","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/art.41441","article-title":"MicroRNA-17-5p Reduces Inflammation and Bone Erosions in mice with Collagen-Induced Arthritis and Directly Targets the JAK\/STAT Pathway in Rheumatoid Arthritis Fibroblast-like Synoviocytes","volume":"72","author":"Najm","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bcp.2026.118515_b0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1098\/rstb.1996.0012","article-title":"Janus kinases in cytokine signalling","volume":"351","author":"Ihle","year":"1996","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.bcp.2026.118515_b0075","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nsmb.2807","article-title":"Structural basis of recognition of interferon-\u03b1 receptor by tyrosine kinase 2","volume":"21","author":"Wallweber","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bcp.2026.118515_b0080","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/annrheumdis-2014-206028","article-title":"The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis","volume":"74","author":"Boyle","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2026.118515_b0085","article-title":"Janus kinase inhibitors in autoimmune diseases","volume":"72 Suppl 2","author":"O'Shea","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2026.118515_b0090","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK-STAT pathway: impact on human disease and therapeutic intervention","volume":"66","author":"O'Shea","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bcp.2026.118515_b0095","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/43213","article-title":"A new protein containing an SH2 domain that inhibits JAK kinases","volume":"387","author":"Endo","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118515_b0100","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.tips.2019.03.001","article-title":"Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease","volume":"40","author":"Durham","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2026.118515_b0105","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1038\/sj.onc.1205537","article-title":"The tumor suppressor activity of SOCS-1","volume":"21","author":"Rottapel","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.118515_b0110","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/s41467-018-04013-1","article-title":"The molecular basis of JAK\/STAT inhibition by SOCS1","volume":"9","author":"Liau","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118515_b0115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.tips.2011.12.003","article-title":"GRK2: multiple roles beyond G protein-coupled receptor desensitization","volume":"33","author":"Evron","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2026.118515_b0120","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1476-5381.2010.00727.x","article-title":"The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets","volume":"160","author":"Penela","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118515_b0125","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.apsb.2021.01.015","article-title":"Targeted inhibition of GRK2 kinase domain by CP-25 to reverse fibroblast-like synoviocytes dysfunction and improve collagen-induced arthritis in rats","volume":"11","author":"Han","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.118515_b0130","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/CM9.0000000000003165","article-title":"Paroxetine alleviates dendritic cell and T lymphocyte activation via GRK2-mediated PI3K-AKT signaling in rheumatoid arthritis","volume":"138","author":"Liu","year":"2025","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.bcp.2026.118515_b0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.apsb.2023.09.013","article-title":"GRK2 inhibits Flt-1(+) macrophage infiltration and its proangiogenic properties in rheumatoid arthritis","volume":"14","author":"Yang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.118515_b0140","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.apsb.2023.12.007","article-title":"GRK2 mediated degradation of SAV1 initiates hyperplasia of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"14","author":"Guo","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.118515_b0145","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41401-021-00654-z","article-title":"TNF-\u03b1 impairs EP4 signaling through the association of TRAF2-GRK2 in primary fibroblast-like synoviocytes","volume":"43","author":"Tai","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2026.118515_b0150","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.apsb.2025.02.031","article-title":"GRK2 activates TRAF2-NF-\u03baB signalling to promote hyperproliferation of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"15","author":"Han","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.118515_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111706","article-title":"Paeoniflorin-6'-O-benzene sulfonate inhibits keratinocyte proliferation by restoring GRK2-JAK1 colocalization in mouse model of psoriasis","volume":"131","author":"Tian","year":"2025","journal-title":"Cell. Signal."},{"issue":"2010","key":"10.1016\/j.bcp.2026.118515_b0160","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2026.118515_b0165","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/ptr.6870","article-title":"Paeoniflorin-6'-o-benzene sulfonate (CP-25) improves vasculitis through inhibiting IL-17A\/JAK\/STAT3 signaling pathway in endothelial cells of HFD CIA rats","volume":"35","author":"Cai","year":"2021","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bcp.2026.118515_b0170","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00011-012-0520-0","article-title":"Combined use of etanercept and MTX restores CD4+\/CD8+ ratio and Tregs in spleen and thymus in collagen-induced arthritis","volume":"61","author":"Huang","year":"2012","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bcp.2026.118515_b0175","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2559.2006.02508.x","article-title":"Synovitis score: discrimination between chronic low-grade and high-grade synovitis","volume":"49","author":"Krenn","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.bcp.2026.118515_b0180","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.molimm.2023.04.001","article-title":"Fibroblast growth factor 10 delays the progression of osteoarthritis by attenuating synovial fibrosis via inhibition of IL-6\/JAK2\/STAT3 signaling in vivo and in vitro","volume":"159","author":"Su","year":"2023","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bcp.2026.118515_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116458","article-title":"Juglone suppresses vasculogenic mimicry in glioma through inhibition of HuR-mediated VEGF-A expression","volume":"227","author":"Luo","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118515_b0190","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0026-895X(24)26486-5","article-title":"Selective regulation of Gq signaling by G protein-coupled receptor kinase 2: direct interaction of kinase N terminus with activated galphaq","volume":"57","author":"Sallese","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118515_b0195","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1074\/jbc.275.12.8469","article-title":"Interaction between the conserved region in the C-terminal domain of GRK2 and rhodopsin is necessary for GRK2 to catalyze receptor phosphorylation","volume":"275","author":"Gan","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118515_b0200","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1016\/j.jmb.2016.10.005","article-title":"Crystal Structure of a complex of the Intracellular Domain of Interferon \u03bb Receptor 1 (IFNLR1) and the FERM\/SH2 Domains of Human JAK1","volume":"428","author":"Zhang","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bcp.2026.118515_b0205","doi-asserted-by":"crossref","first-page":"25760","DOI":"10.1074\/jbc.M500822200","article-title":"The Jak1 SH2 domain does not fulfill a classical SH2 function in Jak\/STAT signaling but plays a structural role for receptor interaction and up-regulation of receptor surface expression","volume":"280","author":"Radtke","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118515_b0210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrrheum.2012.190","article-title":"Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors","volume":"9","author":"Bottini","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bcp.2026.118515_b0215","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/annrheumdis-2018-213588","article-title":"Ectopic RASGRP2 (CalDAG-GEFI) expression in rheumatoid synovium contributes to the development of destructive arthritis","volume":"77","author":"Nakamura","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2026.118515_b0220","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.immuni.2017.01.004","article-title":"Autocrine Loop Involving IL-6 Family Member LIF, LIF Receptor, and STAT4 Drives Sustained Fibroblast production of Inflammatory Mediators","volume":"46","author":"Nguyen","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2026.118515_b0225","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.str.2016.03.023","article-title":"The Structural Basis for Class II Cytokine Receptor Recognition by JAK1","volume":"24","author":"Ferrao","year":"2016","journal-title":"Structure"},{"key":"10.1016\/j.bcp.2026.118515_b0230","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1074\/jbc.M208787200","article-title":"G protein-coupled receptor Kinase 2\/G alpha q\/11 interaction. a novel surface on a regulator of G protein signaling homology domain for binding G alpha subunits","volume":"278","author":"Sterne-Marr","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118515_b0235","doi-asserted-by":"crossref","first-page":"34531","DOI":"10.1074\/jbc.274.49.34531","article-title":"Feedback inhibition of G protein-coupled receptor kinase 2 (GRK2) activity by extracellular signal-regulated kinases","volume":"274","author":"Pitcher","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118515_b0240","doi-asserted-by":"crossref","first-page":"15192","DOI":"10.1074\/jbc.M009130200","article-title":"Regulation of membrane targeting of the G protein-coupled receptor kinase 2 by protein kinase a and its anchoring protein AKAP79","volume":"276","author":"Cong","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118515_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103429","article-title":"Start RA treatment - Biologics or JAK-inhibitors?","volume":"23","author":"Caporali","year":"2024","journal-title":"Autoimmun. Rev."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:06:42Z","timestamp":1791479202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226008579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":49,"alternative-id":["S0006295226008579"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118515","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GRK2\u2013JAK1 binding represses hyperproliferation of fibroblast-like synoviocytes in rheumatoid arthritis by inhibiting STAT3 activation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118515"}}